Potential melanoma target bypasses therapeutic resistance to immune checkpoint blockers
by Jeff Hansen,University of Alabama at BirminghamConstitutive activation of JAK1/2 in IFNγR1KOmelanoma cells. a Identification of a JAK1/2-centric network of activated protein tyrosine ki
Updated on: January 02,2024
9
Potential melanoma target bypasses therapeutic resistance to immune checkpoint blockers
by Jeff Hansen,University of Alabama at BirminghamConstitutive activation of JAK1/2 in IFNγR1KOmelanoma cells. a Identification of a JAK1/2-centric network of activated protein tyrosine ki
Updated on:January 02,2024
9
